Concomitantly, multiple studies have reported gastrointestinal (GI) adverse events with GLP-1 RAs-including nausea, diarrhea, vomiting, constipation, abdaominal pain, and pancreatitis [24]. The gene discussed is GLP1R; the disease is pancreatitis.